Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Clinical Cancer Research

• Publication date

  2000-08-01

• Fields of study

  Medicine

• Identifiers
  PMID 10955799
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder.

  1999influential reference
• Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long-term clinically disease-free melanoma patients.

  1999cited by this paper
• Expression of cytokeratin 20 in the blood of patients with disseminated carcinoma of the pancreas, colon, stomach, and lung

  1999cited by this paper
• Histological Typing of Urinary Bladder Tumours

  1999cited by this paper
• Expression of transitional cell‐specific genes, uroplakin Ia and II, in bladder cancer: Detection of circulating cancer cells in the peripheral blood of metastatic patients

  1999cited by this paper
• Detection of Disseminated Urothelial Cancer Cells in Peripheral Venous Blood by a Cytokeratin 20‐specific Nested Reverse Transcriptase‐Polymerase Chain Reaction

  1999cited by this paper
• Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.

  1999cited by this paper
• Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples.

  1999cited by this paper
• TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancer.

  1999cited by this paper
• Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood.

  1998cited by this paper
• Combined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostate cancer patients: correlation with pathological stage.

  1998cited by this paper
• Detection of cancer cells in peripheral blood of breast cancer patients using reverse transcription-polymerase chain reaction for epidermal growth factor receptor.

  1998cited by this paper
• Expression of Uroplakin Ib and Uroplakin III Genes in Tissues and Peripheral Blood of Patients with Transitional Cell Carcinoma

  1998cited by this paper
• Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells.

  1997cited by this paper
• Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate.

  1997cited by this paper
• The detection of disseminated tumor cells in bone marrow from colorectal‐cancer patients by a cytokeratin‐20‐specific nested reverse‐transcriptase‐polymerase‐chain reaction is related to the stage of disease

  1996cited by this paper
• Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis.

  1996cited by this paper
• Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins.

  1994cited by this paper
• Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins

  1994cited by this paper
• The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas.

  1993cited by this paper
• Urothelial Tumors of the Urinary Tract

  1992influential reference

• Beyond Visualization: Advanced Imaging, Theragnostics and Biomarker Integration in Urothelial Bladder Cancer

  2025influential citation
• Circulating Tumor Cells Predict Response of Neoadjuvant Chemotherapy in Patients with Bladder Cancer: A Preliminary Study

  2023cites this paper
• Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells as a Predictor of Treatment Response in Patients with Urothelial Carcinoma

  2021cites this paper
• Robust Prognostic Subtyping of Muscle-Invasive Bladder Cancer Revealed by Deep Learning-Based Multi-Omics Data Integration

  2021cites this paper
• Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker

  2021cites this paper
• Tumor heterogeneity in muscle-invasive bladder cancer

  2020cites this paper
• Recent advances in microfluidic methods in cancer liquid biopsy.

  2019cites this paper
• Circulating tumor cells in bladder cancer: Emerging technologies and clinical implications foreseeing precision oncology.

  2018cites this paper
• Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring

  2018cites this paper
• Preliminary Evaluation of the Diagnostic Usefulness of Uroplakin 2 with an Assessment of the Antioxidant Potential of Patients with Bladder Cancer

  2018cites this paper
• Detection and Clinical Significance of Circulating Tumor Cells in Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer

  2017cites this paper
• The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies

  2017cites this paper
• Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer

  2017cites this paper
• Circulating Biomarkers in Bladder Cancer

  2016cites this paper
• Dynamics of Cancer-Related Proteins in Patients with Bladder Cancer

  2016cites this paper
• Molecular markers in bladder cancer: Novel research frontiers

  2015cites this paper
• High expression level of preoperative serum Uroplakin III is associated with biologically aggressive bladder cancer.

  2015cites this paper
• Do Circulating Tumor Cells Have a Role in Deciding on Adjuvant Chemotherapy After Radical Cystectomy?

  2015cites this paper
• A newly developed uroplakin II antibody with increased sensitivity in urothelial carcinoma of the bladder.

  2014cites this paper
• Bladder Cancer Detection and Monitoring: Assessment of Urine- and Blood-Based Marker Tests

  2013cites this paper
• Utility of urothelial mRNA markers in blood for staging and monitoring bladder cancer.

  2012cites this paper
• Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis

  2011cites this paper
• [Molecular markers in the diagnostics and therapy of urothelial cancer].

  2010cites this paper
• Molekulare Marker in Diagnostik und Therapie des Urothelkarzinoms

  2010cites this paper
• 9and Significance of Micrometastases

  2010cites this paper
• 301 MOLECULAR MRNA MARKERS TO DETECT AND MONITOR CIRCULATING TUMOUR CELLS IN PERIPHERAL BLOD FROM UROTHELIAL CARCINOMA PATIENTS

  2009cites this paper
• Detection of circulating tumor cells in bladder cancer patients.

  2009cites this paper
• Immunohistochemistry

  2009cites this paper
• Presence and Significance of Micrometastases

  2009cites this paper
• Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer.

  2008cites this paper
• Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma

  2006cites this paper
• Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging.

  2006cites this paper
• Detection of Micrometastases in Pelvic Lymph Nodes in Patients Undergoing Radical Cystectomy for Focally Invasive Bladder Cancer by Real-time Reverse Transcriptase-PCR for Cytokeratin 19 and Uroplakin II

  2005cites this paper
• Transcriptional control of the human urothelial-specific gene, uroplakin Ia.

  2005cites this paper
• Molekulare Prognosemarker des Harnblasenkarzinoms

  2005cites this paper
• Uroplakin II as a promising marker for molecular diagnosis of nodal metastases from bladder cancer: comparison with cytokeratin 20.

  2005cites this paper
• The Road to Cystectomy: Who, When and Why?

  2005cites this paper
• Detection and isolation of circulating tumor cells in urologic cancers: a review.

  2004cites this paper
• Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine.

  2004cites this paper
• Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients

  2004cites this paper
• Drug-induced increase of carcinoembryonic antigen expression in cancer cells.

  2004cites this paper
• When is a negative lymph node really negative? Molecular tools for the detection of lymph node metastasis from urological cancer.

  2004cites this paper
• Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.

  2004cites this paper
• Methylation of a CpG island within the uroplakin Ib promoter: a possible mechanism for loss of uroplakin Ib expression in bladder carcinoma.

  2004cites this paper
• Detection of circulating MUC7‐positive cells by reverse transcription–polymerase chain reaction in bladder cancer patients

  2004cites this paper
• Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease.

  2003cites this paper
• Noninvasive molecular detection of cancer -- the bench and the bedside.

  2003cites this paper
• Usefulness of the Real-Time Reverse Transcription-Polymerase Chain Reaction Assay Targeted to α1,4-N-Acetylglucosaminyltransferase for the Detection of Gastric Cancer

  2003cites this paper
• Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCR.

  2003cites this paper
• Uroplakin gene expression in normal human tissues and locally advanced bladder cancer

  2003cites this paper
• Genetic detection for hematogenous micrometastasis in patients with various types of malignant tumors using Uroplakin II derived primers in polymerase chain reaction.

  2003cites this paper
• [Molecular and cytometric analysis of renal cell carcinoma cells. Concepts, techniques and prospects].

  2003cites this paper
• Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol.

  2002cites this paper
• Identification of human uroplakin II promoter and its use in the construction of CG8840, a urothelium-specific adenovirus variant that eliminates established bladder tumors in combination with docetaxel.

  2002cites this paper
• High Expression of Human Uroplakin Ia in Urinary Bladder Transitional Cell Carcinoma

  2002cites this paper
• [Molecular markers of infiltrating cancer of the bladder].

  2002cites this paper
• The molecular detection of circulating tumor cells in bladder cancer using telomerase activity.

  2002cites this paper
• Marqueurs moléculaires du cancer infiltrant de la vessie

  2002cites this paper
• Adjunct to Multiple Serum Markers Analyses and Demonstration of Its Potential Importance as an for Carcinoembryonic Antigen Messenger RNA : Longitudinal by Nested Reverse Transcription-Polymerase Chain Reaction Detection of Blood-borne Cells in Colorectal Cancer Patients

  2001cites this paper
• Molecular detection and characterization of circulating tumor cells and micrometastases in prostatic, urothelial, and renal cell carcinomas.

  2001cites this paper
• Molecular determination of perivesical and lymph node metastasis after radical cystectomy for urothelial carcinoma of the bladder.

  2001cites this paper
• Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients.

  2001cites this paper
• Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.

  2001cites this paper